Pivotal Bio Venture Partners Investment Advisor LLC Bolt Biotherapeutics, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $136 Million
- Q1 2024
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 1,891,467 shares of BOLT stock, worth $1.4 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
1,891,467
Previous 1,891,467
-0.0%
Holding current value
$1.4 Million
Previous $2.12 Million
25.02%
% of portfolio
1.94%
Previous 0.57%
Shares
1 transactions
Others Institutions Holding BOLT
# of Institutions
40Shares Held
24.3MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA3.52MShares$2.61 Million0.66% of portfolio
-
Tang Capital Management LLC San Diego, CA3.42MShares$2.53 Million0.58% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$2.04 Million0.22% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.42MShares$1.79 Million0.0% of portfolio
-
Newtyn Management, LLC New York, NY1.7MShares$1.26 Million0.51% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $27.9M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...